Xiamen Comfort Science&Technology Group Co Ltd (002614) fair value: what the stock is really worth
We calculate from audited financials what Xiamen Comfort Science&Technology Group Co Ltd is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Xiamen Comfort Science&Technology Group Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
60‑month range ¥4.42 – ¥20.29 · fair‑value band ¥1.74 – ¥3.62 · the ¥5.50 price screens above the ¥2.88 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Xiamen Comfort Science&Technology Group Co., Ltd researches, develops, manufactures, and sells health massage appliances in China and internationally. The company offers massage chairs and appliances; fresh air systems and air purifiers;and other products.
Show more
Xiamen Comfort Science&Technology Group Co., Ltd researches, develops, manufactures, and sells health massage appliances in China and internationally. The company offers massage chairs and appliances; fresh air systems and air purifiers;and other products. It offers its products under the OGAWA, FUJI, IHOCO, medisana, BRI, cozzia, joypal, EASEWELL, and MICODE brand names. The company was founded in 1996 and is based in Xiamen, China.
Stock analysis
Xiamen Comfort Science&Technology Group Co Ltd (002614) currently trades at ¥5.50, while our model-based Fair Value estimate is ¥2.88, implying the stock looks roughly 91.0% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ¥4.72 per share, and 1 of the 17 models we run sit above the ¥5.50 price.
Bear case: the Growth Earnings group reads lowest at ¥0.3700, and 16 of the 17 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥1.74 (bear) to ¥3.62 (bull), the price of ¥5.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Consumer Cyclical sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Xiamen Comfort Science&Technology Group Co Ltd reported revenue of 5.1B CNY in FY2025 versus 7.9B CNY in FY2021, a compound −10.5%/yr. Reported net income was 12.3M CNY in FY2025, compounding −59.5%/yr from FY2021.
Key figures
Market cap 3.4B CNY (≈ $511M) · P/S ratio 0.57 · EPS (TTM) ¥−0.0900 · Dividend yield 1.8% · Net margin 0.2% · Return on equity −1.3% · Return on assets (EBIT) 2.3% · Operating margin −3.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (low confidence).
What moves the price
The share trades about 34% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at 10% fair-value upside, at −48%, 002614 screens richer than that median.
Fair Value models
Bear ¥1.74Fair Value ¥2.88Bull ¥3.62
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.20/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+5.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.3%
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−49.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−50.8%
Dividend (yield on the price)1.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−51% vs −25%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 1%
Compare Xiamen Comfort Science&Technology Group Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Leisure · 192 stocks
Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score52 · Below median
Profitability
Return on assets0% · Below median
Net margin (TTM)−1% · Below median
Operating margin (TTM)−3% · Below median
Growth and dividend
Revenue growth11% · Above median
Dividend yield (TTM)1.8% · Below median
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Leisure median · lower = cheaper
P/B0.10× · Cheapest 25%
P/S (TTM)0.09× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)56· sector 15
PAST (return on equity)0· sector 19
HEALTH (low debt)99· sector 94
DIVIDEND (yield)36· sector 56
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Xiamen Comfort Science&Technology Group Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/002614
Frequently asked questions
Is Xiamen Comfort Science&Technology Group Co Ltd (002614) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of ¥2.88 versus a price of ¥5.50, about −48% upside (overvalued).
What is the fair value of 002614?
Our model-based fair value for Xiamen Comfort Science&Technology Group Co Ltd is ¥2.88 (as of Sep 13, 2026), built from audited fundamentals. The current price: ¥5.50.
What is the quality score of 002614?
Xiamen Comfort Science&Technology Group Co Ltd has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Xiamen Comfort Science&Technology Group Co Ltd (002614)?
Our model-based price target is the fair value of ¥2.88 (as of Sep 13, 2026) from 17 valuation models. Cautious scenario ¥1.74, optimistic scenario ¥3.62. It is a calculation from audited fundamentals, not an analyst target.
What is the Xiamen Comfort Science&Technology Group Co Ltd stock forecast for 2026?
Our models put fair value at ¥2.88, about −48% upside versus a price of ¥5.50 (overvalued). Cautious scenario ¥1.74, optimistic scenario ¥3.62. The calculation is refreshed regularly with new filings.
What is the revenue of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
Xiamen Comfort Science&Technology Group Co Ltd reported trailing-twelve-month revenue of about 5.2B CNY (latest available figure, as of Sep 13, 2026).
Does Xiamen Comfort Science&Technology Group Co Ltd pay a dividend?
Xiamen Comfort Science&Technology Group Co Ltd currently shows a dividend yield of about 1.82% relative to its recent price (as of Sep 13, 2026).
What is the intrinsic value of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Xiamen Comfort Science&Technology Group Co Ltd it is ¥2.88 per share (as of Sep 13, 2026), against a price of ¥5.50. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Xiamen Comfort Science&Technology Group Co Ltd stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 002614 trades above its calculated fair value: price ¥5.50, fair value ¥2.88, a gap of about −48% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 002614?
No. The price is what the market pays today (¥5.50); the fair value is what the company's own numbers justify (¥2.88). For Xiamen Comfort Science&Technology Group Co Ltd the two are ¥2.62 per share apart. That gap is exactly why we show both numbers side by side.
How much is Xiamen Comfort Science&Technology Group Co Ltd worth?
The market values Xiamen Comfort Science&Technology Group Co Ltd at about 3.4B CNY (market capitalisation, as of Sep 13, 2026). Per share that is ¥5.50; our models calculate a fair value of ¥2.88 per share.
What do the bullish and bearish scenarios say about 002614?
Our models span a range for Xiamen Comfort Science&Technology Group Co Ltd: cautious scenario ¥1.74, base ¥2.88, optimistic ¥3.62 per share (as of Sep 13, 2026, price ¥5.50). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
Balance-sheet figures for Xiamen Comfort Science&Technology Group Co Ltd (as of Sep 13, 2026): return on equity −1.3%, debt of 0.02 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is 002614 from its 52-week high?
Xiamen Comfort Science&Technology Group Co Ltd trades at ¥5.50, about 34% below its 52-week high of ¥8.29 and 17% above the low of ¥4.72 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of ¥2.88 is for.
Which stocks are comparable to Xiamen Comfort Science&Technology Group Co Ltd?
From the same area (Consumer Cyclical) we also value ANTA Sports Products Limited, Pop Mart International Group, Amer Sports, Inc, Hasbro, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Xiamen Comfort Science&Technology Group Co Ltd stock attractive at the current price?
The data as of Sep 13, 2026: price ¥5.50, calculated fair value ¥2.88 (−48%), Quality Score 53/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 002614 calculated?
We run Xiamen Comfort Science&Technology Group Co Ltd through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥2.88, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Xiamen Comfort Science&Technology Group Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Xiamen Comfort Science&Technology Group Co Ltd right now?
The price sits above even our optimistic bull case (¥3.62). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (¥1.74 to ¥3.62) leaves room in how you read the outcome.
Where does the earnings growth of Xiamen Comfort Science&Technology Group Co Ltd (002614) come from?
Earnings per share at Xiamen Comfort Science&Technology Group Co Ltd grew −6.5 % a year from 2013 to 2024. Broken into its drivers: revenue per share +6.3 %, EBIT margin −8.4 %, tax rate −2.2 %, residual (interest, one-offs) −1.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Xiamen Comfort Science&Technology Group Co Ltd
How large is the market capitalisation of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
The market capitalisation of Xiamen Comfort Science&Technology Group Co Ltd is 3.4B CNY (≈ $511M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
The price-to-sales ratio of Xiamen Comfort Science&Technology Group Co Ltd is 0.57 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
Earnings per share at Xiamen Comfort Science&Technology Group Co Ltd are ¥−0.0900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
The dividend yield of Xiamen Comfort Science&Technology Group Co Ltd is 1.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
The net margin of Xiamen Comfort Science&Technology Group Co Ltd is 0.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
The return on equity (ROE) of Xiamen Comfort Science&Technology Group Co Ltd is −1.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
On an EBIT basis the return on assets of Xiamen Comfort Science&Technology Group Co Ltd is 2.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Xiamen Comfort Science&Technology Group Co Ltd (002614)?
The operating margin of Xiamen Comfort Science&Technology Group Co Ltd is −3.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Xiamen Comfort Science&Technology Group Co Ltd (002614)?
Revenue at Xiamen Comfort Science&Technology Group Co Ltd is growing +11.2% versus a year earlier (3y avg −5.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Xiamen Comfort Science&Technology Group Co Ltd (002614)?
Earnings per share at Xiamen Comfort Science&Technology Group Co Ltd are growing +53.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Xiamen Comfort Science&Technology Group Co Ltd (002614) generate?
The free cash flow of Xiamen Comfort Science&Technology Group Co Ltd is −210M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Xiamen Comfort Science&Technology Group Co Ltd (002614) carry?
The net debt of Xiamen Comfort Science&Technology Group Co Ltd is 437M CNY (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Xiamen Comfort Science&Technology Group Co Ltd in the live analysis
One click puts Xiamen Comfort Science&Technology Group Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
